Further report on therapeutic effect of abrin and ricin on human cancers.
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D004220:Disulfides / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010940:Plant Proteins / Q000627:therapeutic use*; D012276:Ricin / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy; D014118:Toxins, Biological / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D004220:Disulfides; D010940:Plant Proteins; D014118:Toxins, Biological; D012276:Ricin